
Raia Drogasil SA
BOVESPA:RADL3

Intrinsic Value
The intrinsic value of one
RADL3
stock under the Base Case scenario is
20.81
BRL.
Compared to the current market price of 14.85 BRL,
Raia Drogasil SA
is
Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Raia Drogasil SA
Fundamental Analysis


Revenue & Expenses Breakdown
Raia Drogasil SA
Balance Sheet Decomposition
Raia Drogasil SA
Current Assets | 13.1B |
Cash & Short-Term Investments | 470.2m |
Receivables | 3.9B |
Other Current Assets | 8.7B |
Non-Current Assets | 9.5B |
Long-Term Investments | 13.6m |
PP&E | 6.7B |
Intangibles | 2B |
Other Non-Current Assets | 811.3m |
Free Cash Flow Analysis
Raia Drogasil SA
BRL | |
Free Cash Flow | BRL |
Earnings Waterfall
Raia Drogasil SA
Revenue
|
39.8B
BRL
|
Cost of Revenue
|
-28B
BRL
|
Gross Profit
|
11.8B
BRL
|
Operating Expenses
|
-9.5B
BRL
|
Operating Income
|
2.3B
BRL
|
Other Expenses
|
-1.1B
BRL
|
Net Income
|
1.2B
BRL
|
RADL3 Profitability Score
Profitability Due Diligence
Raia Drogasil SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
Raia Drogasil SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
RADL3 Solvency Score
Solvency Due Diligence
Raia Drogasil SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Score
Raia Drogasil SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RADL3 Price Targets Summary
Raia Drogasil SA
According to Wall Street analysts, the average 1-year price target for
RADL3
is 23.79 BRL
with a low forecast of 17.17 BRL and a high forecast of 32.55 BRL.
Dividends
Current shareholder yield for RADL3 is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RADL3
stock under the Base Case scenario is
20.81
BRL.
Compared to the current market price of 14.85 BRL,
Raia Drogasil SA
is
Undervalued by 29%.